BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24192168)

  • 1. The principles underlying the use of powder diffraction data in solving pharmaceutical crystal structures.
    Shankland K; Spillman MJ; Kabova EA; Edgeley DS; Shankland N
    Acta Crystallogr C; 2013 Nov; 69(Pt 11):1251-9. PubMed ID: 24192168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solving molecular crystal structures from X-ray powder diffraction data: the challenges posed by gamma-carbamazepine and chlorothiazide N,N,-dimethylformamide (1/2) solvate.
    Fernandes P; Shankland K; Florence AJ; Shankland N; Johnston A
    J Pharm Sci; 2007 May; 96(5):1192-202. PubMed ID: 17455337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of crystal structures of active pharmaceutical ingredients from X-ray powder diffraction data: a brief, practical introduction, with fexofenadine hydrochloride as example.
    Brüning J; Schmidt MU
    J Pharm Pharmacol; 2015 Jun; 67(6):773-81. PubMed ID: 25677117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Powder diffraction crystallography of molecular solids.
    Harris KD
    Top Curr Chem; 2012; 315():133-77. PubMed ID: 21952843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallographic characterization of several erythromycin A solvates: the environment of the solvent molecules in the crystal lattice.
    Henry R; Zhang GG
    J Pharm Sci; 2007 May; 96(5):1251-7. PubMed ID: 17455320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isostructurality among solvates of cabazitaxel: X-ray structures and new solvates preparation.
    Xu W; Gong N; Yang S; Zhang N; He L; Du G; Lu Y
    J Pharm Sci; 2015 Apr; 104(4):1256-62. PubMed ID: 25675889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second SH3 domain of ponsin solved from powder diffraction.
    Margiolaki I; Wright JP; Wilmanns M; Fitch AN; Pinotsis N
    J Am Chem Soc; 2007 Sep; 129(38):11865-71. PubMed ID: 17784760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphs and solvates of nicardipine hydrochloride. Selective stabilization of different diastereomeric racemates.
    Moreno-Calvo E; Muntó M; Wurst K; Ventosa N; Masciocchi N; Veciana J
    Mol Pharm; 2011 Apr; 8(2):395-404. PubMed ID: 21166472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure determination of the β-cyclodextrin-p-aminobenzoic acid inclusion complex from powder X-ray diffraction data.
    Guo P; Su Y; Cheng Q; Pan Q; Li H
    Carbohydr Res; 2011 May; 346(7):986-90. PubMed ID: 21440247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Stoichiometry of Multicomponent Crystals Using Only X-ray Powder Diffraction Data.
    Maguire CK; Brunskill AP
    Mol Pharm; 2015 Jun; 12(6):2061-7. PubMed ID: 25872584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structures of mono-unsaturated triacylglycerols. V. The beta'(1)-2, beta'-3 and beta(2)-3 polymorphs of 1,3-dilauroyl-2-oleoylglycerol (LaOLa) from synchrotron and laboratory powder diffraction data.
    van Mechelen JB; Goubitz K; Pop M; Peschar R; Schenk H
    Acta Crystallogr B; 2008 Dec; 64(Pt 6):771-9. PubMed ID: 19029706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure determination from conventional powder diffraction data: application to hydrates, hydrochloride salts, and metastable polymorphs.
    Stephenson GA
    J Pharm Sci; 2000 Jul; 89(7):958-66. PubMed ID: 10861598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure Determination and Characterization of a Family of Primary Alcohol Solvates.
    Vasudevan KV; Peterson ML
    J Pharm Sci; 2018 Jun; 107(6):1489-1497. PubMed ID: 29421220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clarithromycin form I determined by synchrotron X-ray powder diffraction.
    Noguchi S; Miura K; Fujiki S; Iwao Y; Itai S
    Acta Crystallogr C; 2012 Feb; 68(Pt 2):o41-4. PubMed ID: 22307251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-ray powder diffraction structure determination of gamma-butyrolactone at 180 K: phase-problem solution from the lattice energy minimization with two independent molecules.
    Papoular RJ; Allouchi H; Chagnes A; Dzyabchenko A; Carré B; Lemordant D; Agafonov V
    Acta Crystallogr B; 2005 Jun; 61(Pt 3):312-20. PubMed ID: 15914896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
    Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
    J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of an organic crystal structural model based on combined electron and powder X-ray diffraction data and the charge flipping algorithm.
    Wu J; Sheng Zhao Y; Hu H; Huang J; Zuo JM; Dravid VP
    Ultramicroscopy; 2011 Jun; 111(7):812-6. PubMed ID: 20880632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mg(1 + x)Ir(1 - x) (x = 0, 0.037 and 0.054), a binary intermetallic compound with a new orthorhombic structure type determined from powder and single-crystal X-ray diffraction.
    Cerný R; Renaudin G; Favre-Nicolin V; Hlukhyy V; Pöttgen R
    Acta Crystallogr B; 2004 Jun; 60(Pt 3):272-81. PubMed ID: 15148430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure determination of seven phases and solvates of Pigment Yellow 183 and Pigment Yellow 191 from X-ray powder and single-crystal data.
    Ivashevskaya SN; van de Streek J; Djanhan JE; Brüning J; Alig E; Bolte M; Schmidt MU; Blaschka P; Höffken HW; Erk P
    Acta Crystallogr B; 2009 Apr; 65(Pt 2):212-22. PubMed ID: 19299877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.